Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

The epigenetic regulation of CXCL14 plays a role in the pathobiology of oral cancers.

Nakayama R, Arikawa K, Bhawal UK.

J Cancer. 2017 Aug 25;8(15):3014-3027. doi: 10.7150/jca.21169. eCollection 2017.

2.

Identification of novel methylated targets in colorectal cancer by microarray analysis and construction of co-expression network.

Li D, Guo J, Wang S, Zhu L, Shen Z.

Oncol Lett. 2017 Sep;14(3):2643-2648. doi: 10.3892/ol.2017.6506. Epub 2017 Jun 30.

3.

DNA hypomethylation of CBS promoter induced by folate deficiency is a potential noninvasive circulating biomarker for colorectal adenocarcinomas.

Xue G, Lu CJ, Pan SJ, Zhang YL, Miao H, Shan S, Zhu XT, Zhang Y.

Oncotarget. 2017 May 18;8(31):51387-51401. doi: 10.18632/oncotarget.17988. eCollection 2017 Aug 1.

4.

Analysis of the DNA methylation level of cancer-related genes in colorectal cancer and the surrounding normal mucosa.

Sugai T, Yoshida M, Eizuka M, Uesugii N, Habano W, Otsuka K, Sasaki A, Yamamoto E, Matsumoto T, Suzuki H.

Clin Epigenetics. 2017 May 18;9:55. doi: 10.1186/s13148-017-0352-4. eCollection 2017.

5.

Epigenetic silencing of protocadherin 10 in colorectal cancer.

Zhong X, Shen H, Mao J, Zhang J, Han W.

Oncol Lett. 2017 Apr;13(4):2449-2453. doi: 10.3892/ol.2017.5733. Epub 2017 Feb 13.

6.

Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers.

Andrew AS, Baron JA, Butterly LF, Suriawinata AA, Tsongalis GJ, Robinson CM, Amos CI.

Int J Mol Sci. 2017 Mar 2;18(3). pii: E535. doi: 10.3390/ijms18030535.

7.

Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer.

McAnena P, Brown JA, Kerin MJ.

Cancers (Basel). 2017 Jan 8;9(1). pii: E5. doi: 10.3390/cancers9010005. Review.

8.

Terahertz molecular resonance of cancer DNA.

Cheon H, Yang HJ, Lee SH, Kim YA, Son JH.

Sci Rep. 2016 Nov 15;6:37103. doi: 10.1038/srep37103.

9.

Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells.

Sabit H, Samy MB, Said OA, El-Zawahri MM.

Genet Res Int. 2016;2016:8348450. Epub 2016 Oct 24.

10.

Enhancement of Pathologist's Routine Practice: Reuse of DNA Extracted from Immunostained Formalin-fixed Paraffin-embedded (FFPE) Slides in Downstream Molecular Analysis of Cancer.

Al-Attas A, Assidi M, Al-Maghrabi J, Dallol A, Schulten HJ, Abu-Elmagd M, Chaudhary A, Abuzenadah A, Budowle B, Buhmeida A, Al-Qahtani M.

Cancer Genomics Proteomics. 2016 09-10;13(5):399-406.

11.

Classification of Colon Cancer Patients Based on the Methylation Patterns of Promoters.

Choi W, Lee J, Lee JY, Lee SM, Kim DW, Kim YJ.

Genomics Inform. 2016 Jun;14(2):46-52. doi: 10.5808/GI.2016.14.2.46. Epub 2016 Jun 30.

12.

Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer.

Matthaios D, Balgkouranidou I, Karayiannakis A, Bolanaki H, Xenidis N, Amarantidis K, Chelis L, Romanidis K, Chatzaki A, Lianidou E, Trypsianis G, Kakolyris S.

Oncol Lett. 2016 Jul;12(1):748-756. Epub 2016 Jun 1.

13.

Promoter hypermethylation and downregulation of the FAS gene may be involved in colorectal carcinogenesis.

Manoochehri M, Borhani N, Karbasi A, Koochaki A, Kazemi B.

Oncol Lett. 2016 Jul;12(1):285-290. Epub 2016 May 16.

14.

Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer.

Galamb O, Kalmár A, Péterfia B, Csabai I, Bodor A, Ribli D, Krenács T, Patai ÁV, Wichmann B, Barták BK, Tóth K, Valcz G, Spisák S, Tulassay Z, Molnár B.

Epigenetics. 2016 Aug 2;11(8):588-602. doi: 10.1080/15592294.2016.1190894. Epub 2016 May 31.

15.

Field Cancerization in Sporadic Colon Cancer.

Park SK, Song CS, Yang HJ, Jung YS, Choi KY, Koo DH, Kim KE, Jeong KU, Kim HO, Kim H, Chun HK, Park DI.

Gut Liver. 2016 Sep 15;10(5):773-80. doi: 10.5009/gnl15334. Erratum in: Gut Liver. 2016 Nov 15;10 (6):981.

16.

Methylation pattern of ALX4 gene promoter as a potential biomarker for blood-based early detection of colorectal cancer.

Salehi R, Atapour N, Vatandoust N, Farahani N, Ahangari F, Salehi AR.

Adv Biomed Res. 2015 Nov 30;4:252. doi: 10.4103/2277-9175.170677. eCollection 2015.

17.

The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation.

Yazdani Y, Farazmandfar T, Azadeh H, Zekavatian Z.

J Biomed Sci. 2016 Jan 19;23:9. doi: 10.1186/s12929-016-0228-5.

18.

Identifying molecular subtypes in human colon cancer using gene expression and DNA methylation microarray data.

Ren Z, Wang W, Li J.

Int J Oncol. 2016 Feb;48(2):690-702. doi: 10.3892/ijo.2015.3263. Epub 2015 Nov 24.

19.

DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.

Kalmár A, Péterfia B, Hollósi P, Galamb O, Spisák S, Wichmann B, Bodor A, Tóth K, Patai ÁV, Valcz G, Nagy ZB, Kubák V, Tulassay Z, Kovalszky I, Molnár B.

BMC Cancer. 2015 Oct 19;15:736. doi: 10.1186/s12885-015-1687-x.

20.

Screening of potential diagnostic markers and therapeutic targets against colorectal cancer.

Tian X, Sun D, Zhao S, Xiong H, Fang J.

Onco Targets Ther. 2015 Jul 8;8:1691-9. doi: 10.2147/OTT.S81621. eCollection 2015.

Supplemental Content

Support Center